TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8762699

Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks) in patients with Chagas' disease
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks) in idiopathic patients
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: sotalol (320 mg po/d for 4 weeks) in ischemic and hypertensive patients
Number of subjects: 90
Study: 1924656

Group type: EXPERIMENTAL
Intervention: Standard Blood Glucose Awareness Training (BGAT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intensive Blood Glucose Awareness Training (BGAT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control
Number of subjects: 39
Study: 6682669

Group type: EXPERIMENTAL
Intervention: Doxycycline monotherapy
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Isoconazole nitrate (300 mg/day and 600 mg/day for 14 days)
Number of subjects: 29
Study: 31318821

Group type: EXPERIMENTAL
Intervention: Cognitive-emotional intervention (5 sessions, 60 to 90 minutes each, held twice a week)
Number of subjects: 100
Study: 29370892

Group type: EXPERIMENTAL
Intervention: SILA (single incision laparoscopic appendectomy)
Number of subjects: 80

Group type: COMPARATOR
Intervention: LA (conventional laparoscopy using three trocars)
Number of subjects: 80
Study: 26449338

Group type: EXPERIMENTAL
Intervention: 5 mg morphine intravenously
Number of subjects: 24

Group type: COMPARATOR
Intervention: 180 mg ticagrelor
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 25584463

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 23870811

Group type: EXPERIMENTAL
Intervention: D-cycloserine (50 mg)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 20658442

Group type: EXPERIMENTAL
Intervention: L-carnitine 1 g iv after each HD session for 12 weeks
Number of subjects: 10
Study: 18076732

Group type: EXPERIMENTAL
Intervention: Oil-assisted technique (corn seed oil injection) - Group B
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Warm water method - Group C
Number of subjects: 510

Group type: COMPARATOR
Intervention: Standard lubricating method (water-soluble jelly) - Group A (Control)
Number of subjects: 510
Study: 17697220

Group type: EXPERIMENTAL
Intervention: Buccal midazolam (0.2 mg x kg(‐1))
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 12677618

Group type: EXPERIMENTAL
Intervention: Forearm rescue cuff
Number of subjects: 10
Study: 11077390

Group type: EXPERIMENTAL
Intervention: Calibrated cold stimulation of root areas
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Electric testing of the root
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cold testing of the root
Number of subjects: 16
Study: 8797468

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine hydrochloride (ALCAR) 3 g/day
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo (1 g tid)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine hydrochloride (ALCAR)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431
Study: 1521671

Group type: EXPERIMENTAL
Intervention: 20 mg/day zolpidem
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 10 mg/day zolpidem
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 6220336

Group type: EXPERIMENTAL
Intervention: Duxil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30703126

Group type: EXPERIMENTAL
Intervention: Cash transfer intervention (conditional or unconditional on school enrollment)
Number of subjects: 1708

Group type: COMPARATOR
Intervention: Control group (no cash transfer)
Number of subjects: 1708
Study: 29913528

Group type: EXPERIMENTAL
Intervention: Camphor-Crataegus Combination (CCC) - 20 drops of a fixed combination of natural D-camphor and an ethanolic extract from fresh Crataegus berries
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (ethanolic placebo)
Number of subjects: 0
Study: 27074340

Group type: EXPERIMENTAL
Intervention: Crack/cocaine exposure in utero (EN)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Maternal history of crack/cocaine use
Number of subjects: 156
Study: 23916115

Group type: EXPERIMENTAL
Intervention: F‐SCLs
Number of subjects: 16

Group type: COMPARATOR
Intervention: S‐SCLs
Number of subjects: 16
Study: 22385586

Group type: EXPERIMENTAL
Intervention: Educational intervention (written and oral program on hypertension and cardiovascular risk)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 19290011

Group type: EXPERIMENTAL
Intervention: Lifestyle interventions
Number of subjects: 1916
Study: 17198742

Group type: EXPERIMENTAL
Intervention: Multivitamin and multimineral supplementation (one tablet daily)
Number of subjects: 910

Group type: COMPARATOR
Intervention: Placebo (matching placebo tablet daily)
Number of subjects: 910
Study: 15030624

Group type: EXPERIMENTAL
Intervention: Self-assessment of intentions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Evaluation of others' intentions
Number of subjects: 0
Study: 11588818

Group type: EXPERIMENTAL
Intervention: Nd‐YAG laser irradiation with acidulated phosphate fluoride solution (APF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no laser treatment)
Number of subjects: 20
Study: 9521392

Group type: EXPERIMENTAL
Intervention: Double-gloving method
Number of subjects: 2058

Group type: COMPARATOR
Intervention: Single-gloving method
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Double outer-gloves
Number of subjects: 2058

Group type: EXPERIMENTAL
Intervention: Matched outer and inner perforation
Number of subjects: 2058
Study: 8019170

Group type: EXPERIMENTAL
Intervention: Pelvic floor exercise only (group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Pelvic floor exercise plus vaginal cones (group B)
Number of subjects: 46
Study: 2609138

Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 14
Study: 1092419

Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 831

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 831
Study: 31959492

Group type: EXPERIMENTAL
Intervention: Olaparib 50 mg BID
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Olaparib 100 mg BID
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Olaparib 200 mg BID
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: IV paclitaxel 135 mg/m2/3 h + IV bevacizumab 15 mg/kg + IP cisplatin 75 mg/m2 + IP paclitaxel 60 mg/m2
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Maintenance olaparib 300 mg BID and bevacizumab 15 mg/kg Day 1
Number of subjects: 17

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 17
Study: 29659918

Group type: EXPERIMENTAL
Intervention: Total dairy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Unflavored milk
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Reduced fat dairy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Low fat/fat-free dairy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverage intake
Number of subjects: 91
Study: 28460182

Group type: EXPERIMENTAL
Intervention: Nitrate and citrulline supplementation (1200 mg nitrate and 6 g citrulline)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 25868877

Group type: EXPERIMENTAL
Intervention: TMP grade 2-3
Number of subjects: 89
Study: 23991206

Group type: EXPERIMENTAL
Intervention: LDL cholesterol
Number of subjects: 12
Study: 20661750

Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoid resection (LSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open sigmoid resection (OSR)
Number of subjects: 0
Study: 19248193

Group type: EXPERIMENTAL
Intervention: Telmisartan (20 mg o.d.)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Valsartan (80 mg o.d.)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both Telmisartan and Valsartan
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 54

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 54
Study: 17393189

Group type: EXPERIMENTAL
Intervention: Oral cryotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard oral care (Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oral cryotherapy (in autologous setting)
Number of subjects: 80
Study: 14977818

Group type: EXPERIMENTAL
Intervention: Flt3 ligand (FL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 11125386

Group type: EXPERIMENTAL
Intervention: Periurethral autologous fat injection
Number of subjects: 68

Group type: COMPARATOR
Intervention: Saline injection (placebo)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Complications from fat injection
Number of subjects: 68
Study: 9543148

Group type: EXPERIMENTAL
Intervention: c-kit mRNA expression detected by RT-PCR in oocytes and granulosa cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soluble c-kit protein presence measured by Western blot analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concentration of soluble c-kit in follicular fluid measured by enzyme-linked immunosorbent assay
Number of subjects: 0
Study: 8047812

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 45
Study: 3195995

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (250 mg orally, twice daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (160 mg of trimethoprim and 800 mg of sulfamethoxazole orally, twice daily)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 45
Study: 29741660

Group type: EXPERIMENTAL
Intervention: IV lidocaine (75 mg if <50 kg, 100 mg if 50-100 kg, 150 mg if >100 kg) over 10 minutes, followed by a 50-minute IV lidocaine infusion of the same dose
Number of subjects: 32

Group type: COMPARATOR
Intervention: Provider-chosen dose of morphine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: IV lidocaine
Number of subjects: 32

Group type: COMPARATOR
Intervention: IV morphine
Number of subjects: 32
Study: 28217891

Group type: EXPERIMENTAL
Intervention: Comprehensive Behavioral Intervention (CBI)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard of Care Exercise (SCE)
Number of subjects: 44
Study: 25607909

Group type: EXPERIMENTAL
Intervention: Efinaconazole topical solution, 10%
Number of subjects: 1655

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 1655
Study: 24649785

Group type: EXPERIMENTAL
Intervention: Theophylline 250 mg three times per day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acetaminophen 500 mg three times per day
Number of subjects: 60
Study: 21777163

Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 404
Study: 18161012

Group type: EXPERIMENTAL
Intervention: THC (60 mg/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lofexidine (2.4 mg/day)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: THC (60 mg/day) combined with Lofexidine (2.4 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 16649886

Group type: EXPERIMENTAL
Intervention: Walking speed measurements
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Functional Ambulation Categories (FAC) scores
Number of subjects: 73
Study: 12648028

Group type: EXPERIMENTAL
Intervention: 20 mg immediate‐release tablet of ximelagatran with breakfast
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg immediate‐release tablet of ximelagatran while fasting
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 7.5 mg subcutaneous injection of ximelagatran
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 2mg intravenous infusion of melagatran
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: APTT measurement
Number of subjects: 18
Study: 12088943

Group type: EXPERIMENTAL
Intervention: rapacuronium
Number of subjects: 10

Group type: COMPARATOR
Intervention: mivacurium
Number of subjects: 10
Study: 9695300

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (0.15 mg/kg in 2 mL saline)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Saline nebulization (control group)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Mist in a tent (control group)
Number of subjects: 156
Study: 7867139

Group type: EXPERIMENTAL
Intervention: Daily regimen of amphotericin B (escalating dose starting at 0.05 mg/kg to 1 mg/kg, total dose of 20 mg/kg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Alternate-day regimen of amphotericin B (escalating dose starting at 0.05 mg/kg to 1 mg/kg, then given on alternate days)
Number of subjects: 80
Study: 2502344

Group type: EXPERIMENTAL
Intervention: Early weight-bearing
Number of subjects: 99

Group type: COMPARATOR
Intervention: Late weight-bearing
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Internal fixation with cerclage wires, staples, and pins
Number of subjects: 99
Study: 335772

Group type: EXPERIMENTAL
Intervention: SnF2 (0.2%)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SnF2 (0.3%)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chlorhexidine (0.1%)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 12
Study: 28279137

Group type: EXPERIMENTAL
Intervention: Customized spiritual program
Number of subjects: 5339
Study: 25992622

Group type: EXPERIMENTAL
Intervention: Normobaric hyperoxia at FiO2 100% over an endotracheal tube for 3 hours
Number of subjects: 44

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Normobaric hyperoxia
Number of subjects: 44
Study: 23453761

Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 2203

Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 2203

Group type: EXPERIMENTAL
Intervention: Both groups (Off-pump and On-pump)
Number of subjects: 2203
Study: 21406646

Group type: EXPERIMENTAL
Intervention: High-dose clopidogrel (600-mg initial dose, 150 mg daily thereafter)
Number of subjects: 2214

Group type: COMPARATOR
Intervention: Standard-dose clopidogrel (no additional loading dose, 75 mg daily)
Number of subjects: 2214

Group type: EXPERIMENTAL
Intervention: High-dose clopidogrel
Number of subjects: 2214

Group type: COMPARATOR
Intervention: Standard-dose clopidogrel
Number of subjects: 2214
Study: 19090775

Group type: EXPERIMENTAL
Intervention: Formula-feed (FF) with zidovudine prophylaxis
Number of subjects: 1116

Group type: EXPERIMENTAL
Intervention: Breast-feed (BF) with zidovudine prophylaxis
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Maternal receipt of nevirapine
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Maternal HIV-1 RNA levels in plasma
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Maternal HIV-1 RNA levels in breast milk
Number of subjects: 1116
Study: 17014529

Group type: EXPERIMENTAL
Intervention: Bonded amalgam restoration
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bonded composite resin restoration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional amalgam restoration
Number of subjects: 120

Group type: COMPARATOR
Intervention: No restoration (MOD cavities)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Endodontic access cavities prepared
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intact teeth
Number of subjects: 120
Study: 12723102

Group type: EXPERIMENTAL
Intervention: Colgate Actibrush (battery-powered toothbrush)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Crest SpinBrush (battery-powered toothbrush)
Number of subjects: 80
Study: 11202860

Group type: EXPERIMENTAL
Intervention: Surgical retreatment
Number of subjects: 92

Group type: COMPARATOR
Intervention: Nonsurgical retreatment
Number of subjects: 92
Study: 9488197

Group type: EXPERIMENTAL
Intervention: Amlodipine-lovastatin combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine alone
Number of subjects: 0
Study: 8363987

Group type: EXPERIMENTAL
Intervention: Audiotapes of initial cancer consultation
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Individualised letters
Number of subjects: 194

Group type: COMPARATOR
Intervention: Audiotapes
Number of subjects: 194
Study: 30721948

Group type: EXPERIMENTAL
Intervention: No red meat group (N = 48)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Fiber group (N = 44)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (N = 40)
Number of subjects: 132
Study: 28697676

Group type: EXPERIMENTAL
Intervention: Laser therapy (LST)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral appliance therapy (OA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Counseling (CSL)
Number of subjects: 30
Study: 27126223

Group type: EXPERIMENTAL
Intervention: Axial implants (2 anterior/2 posterior)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tilted implants (2 anterior axial/2 distal tilted)
Number of subjects: 41
Study: 24686029

Group type: EXPERIMENTAL
Intervention: USG‐PVB with 30 mL of 0.5% ropivacaine (3 injections of 10 mL each at right T5 and bilateral T8)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: USG‐PVB with 30 mL of 0.5% ropivacaine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline injection of 10 mL at every site (control group)
Number of subjects: 52
Study: 22612662

Group type: EXPERIMENTAL
Intervention: Rectal misoprostol (600 µg)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Oxytocin infusion (20 IU in 500 mL)
Number of subjects: 264
Study: 20382179

Group type: EXPERIMENTAL
Intervention: Keep Active Minnesota (KAM) intervention; N=523
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Usual Care (UC); N=526
Number of subjects: 1049
Study: 18759783

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 517
Study: 16362784

Group type: EXPERIMENTAL
Intervention: Repp86 expression in OSCC
Number of subjects: 69

Group type: COMPARATOR
Intervention: Normal oral mucosa
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Correlation with Ki-67
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Correlation with topoisomerase IIalpha
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Ki-67 and topoisomerase IIalpha levels
Number of subjects: 69
Study: 12528093

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-acupoint acupuncture
Number of subjects: 15

Group type: COMPARATOR
Intervention: No-needle acupuncture control
Number of subjects: 15
Study: 9987041

Group type: EXPERIMENTAL
Intervention: PTCA (Percutaneous Transluminal Coronary Angioplasty)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 0
Study: 8700066

Group type: EXPERIMENTAL
Intervention: Regular practice of Basic Life Support (BLS) skills; specific details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teacher-student ratio during BLS training; specific details not available.
Number of subjects: 0
Study: 1897350

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Morphine infusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Indomethacin infusion
Number of subjects: 45
Study: 6349411

Group type: EXPERIMENTAL
Intervention: Epidural buprenorphine (60 micrograms in 10 ml)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epidural morphine (2 mg in 10 ml of normal saline)
Number of subjects: 0
Study: 31522031

Group type: EXPERIMENTAL
Intervention: tiotropium/olodaterol 5/5 μg via Respimat inhaler
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 28723852

Group type: EXPERIMENTAL
Intervention: Skin barrier cream applied 3 times a day
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Skin barrier cream
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no skin barrier cream)
Number of subjects: 33
Study: 26600564

Group type: EXPERIMENTAL
Intervention: BiOSS LIM stent
Number of subjects: 202

Group type: COMPARATOR
Intervention: rDES
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: BiOSS LIM stent (FKBI subgroup)
Number of subjects: 202

Group type: COMPARATOR
Intervention: rDES (FKBI subgroup)
Number of subjects: 202
Study: 24894026

Group type: EXPERIMENTAL
Intervention: Thirst bundle (oral swab wipes, sterile ice-cold water sprays, lip moisturizer)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 252
Study: 21388237

Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Nortriptyline (tricyclic antidepressant)
Number of subjects: 494
Study: 19333944

Group type: EXPERIMENTAL
Intervention: golimumab 50 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: golimumab 100 mg
Number of subjects: 405

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 405
Study: 17961421

Group type: EXPERIMENTAL
Intervention: Carvedilol (target dose of 50 mg/d, actual achieved dose 36.25 +/- 14.31 mg/d in group 1 and 25.97 +/- 8.83 mg/d in group 2)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Carvedilol treatment
Number of subjects: 65
Study: 15368596

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 415
Study: 11452745

Group type: EXPERIMENTAL
Intervention: Physical wellbeing scale measuring headache, abdominal pain, and backache.
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Mental wellbeing scale measuring fatigue, stress, fear, depression, loneliness, helplessness, feeling of guilt, and low self‐complacency.
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Social wellbeing scale measuring perceived social support, relationship with mother, father, friends, and teacher.
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Total wellbeing scale.
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Five-point Likert scale for assessing wellbeing indicators.
Number of subjects: 445
Study: 9509226

Group type: EXPERIMENTAL
Intervention: Apply nitroglycerin ointment and stop i.v. nitroglycerin 30 minutes later
Number of subjects: 200

Group type: COMPARATOR
Intervention: Decrease the dose of i.v. nitroglycerin by 10 micrograms/min every 15 minutes, apply one half the dose of nitroglycerin ointment when the original i.v. dose has been decreased by one half, and apply the full dose of the ointment when the i.v. nitroglycerin is stopped
Number of subjects: 200